FDA Approves Avanir’s Acute Migraine Candidate

The FDA has granted approval to Avanir Pharmaceuticals’ Onzetra Xsail for the acute treatment of migraine with or without aura in adults.

A combination product, Onzetra Xsail delivers sumatriptan powder through the Xsail breath-powered delivery device. Sumatriptan previously has been approved by the FDA in tablet and injectable forms.